MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

10 Feb 2024 Evaluate
The sales moved up 37.97% to Rs. 388.59 millions for the December 2023 quarter as compared to Rs. 281.65 millions during the year-ago period.Net Profit recorded in the quarter ended December 2023 rise to 32.68% to Rs. 130.12  millions  compared to R. 98.07 millions in corresponding previous quarter.Operating profit for the quarter ended December 2023 rose to 187.49 millions as compared to 139.17 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 388.59 281.65 37.97 1281.01 1208.00 6.04 1489.73 1148.54 29.71
Other Income 10.04 18.06 -44.41 30.80 46.25 -33.41 60.24 40.50 48.74
PBIDT 187.49 139.17 34.72 611.50 639.17 -4.33 802.42 620.96 29.22
Interest 0.79 0.71 11.27 1.55 1.75 -11.43 2.01 8.28 -75.72
PBDT 186.70 138.46 34.84 609.95 637.42 -4.31 800.41 612.68 30.64
Depreciation 9.78 6.58 48.63 26.11 18.07 44.49 25.76 22.33 15.36
PBT 176.92 131.88 34.15 583.84 619.35 -5.73 774.65 590.35 31.22
TAX 46.80 33.81 38.42 151.09 156.58 -3.51 194.96 154.10 26.52
Deferred Tax 0.72 1.77 -59.32 2.79 2.51 11.16 2.55 0.72 254.17
PAT 130.12 98.07 32.68 432.75 462.77 -6.49 579.69 436.25 32.88
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 48.25 49.41 -2.35 47.74 52.91 -9.78 53.86 54.07 -0.37
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..